Earum Pharmaceuticals is currently trading at Rs. 10.79, up by 0.51 points or 4.96% from its previous closing of Rs. 10.28 on the BSE.
The scrip opened at Rs. 10.79 and has touched a high and low of Rs. 10.79 and Rs. 10.50 respectively. So far 812699 shares were traded on the counter.
The BSE group ‘B’ stock of face value Rs. 2 has touched a 52 week high of Rs. 26.40 on 23-Sep-2021 and a 52 week low of Rs. 4.75 on 08-Jun-2021.
Last one week high and low of the scrip stood at Rs. 11.10 and Rs. 10.00 respectively. The current market cap of the company is Rs. 63.41 crore.
The promoters holding in the company stood at 70.04%, while Non-Institutions held 29.96% stake in the company.
Earum Pharmaceuticals has signed digital Memorandum of Understanding (MoU) with Government of Gujarat to make an investment of around Rs 50 crore by establishing manufacturing unit of Pharma Finished formulation / API. The proposed expansion is subject to various regulatory and legal permissions / registrations / approvals and clearances.
Earum Pharmaceuticals is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products.